Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M (2020) Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 395:200–211

Article  PubMed  PubMed Central  Google Scholar 

Otto GP, Sossdorf M, Claus RA, Rodel J, Menge K, Reinhart K, Bauer M, Riedemann NC (2011) The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care 15:R183

Article  PubMed  PubMed Central  Google Scholar 

Zhao GJ, Li D, Zhao Q, Song JX, Chen XR, Hong GL, Li MF, Wu B, Lu ZQ (2016) Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study. Sci Rep 6:38361

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Hu Y, Zhang J, Shen Y, Huang J, Yin J, Wang P, Fan Y, Wang J, Lu S, Yang Y, Yan L, Li K, Song Z, Tong C, Du S (2019) Clinical characteristics, risk factors, immune status and prognosis of secondary infection of sepsis: a retrospective observational study. BMC Anesthesiol 19:185

Article  PubMed  PubMed Central  Google Scholar 

Drewry AM, Ablordeppey EA, Murray ET, Beiter ER, Walton AH, Hall MW, Hotchkiss RS. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study. Crit Care. 2016;20.

Hall MW, Gavrilin MA, Knatz NL, Duncan MD, Fernandez SA, Wewers MD (2007) Monocyte mRNA phenotype and adverse outcomes from pediatric multiple organ dysfunction syndrome. Pediatr Res 62:597–603

Article  CAS  PubMed  Google Scholar 

Muszynski JA, Nofziger R, Moore-Clingenpeel M, Greathouse K, Anglim L, Steele L, Hensley J, Hanson-Huber L, Nateri J, Ramilo O, Hall MW (2018) Early immune function and duration of organ dysfunction in critically iii children with sepsis. Am J Respir Crit Care Med 198:361–369

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe E, Thampy LK, Hotchkiss RS (2018) Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike. Acute Med Surg 5:309–315

Article  PubMed  PubMed Central  Google Scholar 

Boomer JS, Green JM, Hotchkiss RS (2014) The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence 5:45–56

Article  PubMed  Google Scholar 

Mazer MB, Caldwell CC, Hanson J, Mannion D, Turnbull IR, Drewry A, Osborne D, Walton A, Blood T, Moldawer LL, Brakenridge S, Remy KE, Hotchkiss RS (2021) A whole blood enzyme-linked immunospot assay for functional immune endotyping of septic patients. J Immunol 206:23–36

Article  CAS  PubMed  Google Scholar 

Bonavia AS, Samuelsen A, Chroneos ZC, Halstead ES (2022) Comparison of rapid cytokine immunoassays for functional immune phenotyping. Front Immunol 13:940030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Subbe CP, Kruger M, Rutherford P, Gemmel L (2001) Validation of a modified early warning score in medical admissions. QJM 94:521–526

Article  CAS  PubMed  Google Scholar 

Gardner-Thorpe J, Love N, Wrightson J, Walsh S, Keeling N (2006) The value of Modified Early Warning Score (MEWS) in surgical in-patients: a prospective observational study. Ann R Coll Surg Engl 88:571–575

Article  CAS  PubMed  PubMed Central  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

Article  CAS  PubMed  Google Scholar 

Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829

Article  CAS  PubMed  Google Scholar 

Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA-J Am Med Assoc 286:1754–1758

Article  CAS  Google Scholar 

Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 26:1793–1800

Article  CAS  PubMed  Google Scholar 

Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255–268

Article  CAS  PubMed  Google Scholar 

Billiau A (1996) Interferon-gamma: biology and role in pathogenesis. Adv Immunol 62:61–130

Article  CAS  PubMed  Google Scholar 

Beutler B, Cerami A (1989) The biology of cachectin/TNF—a primary mediator of the host response. Annu Rev Immunol 7:625–655

Article  CAS  PubMed  Google Scholar 

Brands X, Uhel F, van Vught LA, Wiewel MA, Hoogendijk AJ, Lutter R, Schultz MJ, Scicluna BP, van der Poll T (2022) Immune suppression is associated with enhanced systemic inflammatory, endothelial and procoagulant responses in critically ill patients. PLoS ONE 17:e0271637

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Vught LA, Wiewel MA, Hoogendijk AJ, Sciciuna BP, Belkasim-Bohoudi H, Horn J, Schultz MJ, van der Poll T (2015) Reduced responsiveness of blood leukocytes to lipopolysaccharide does not predict nosocomial infections in critically ill patients. Shock 44:110–114

Article  PubMed  Google Scholar 

Adamik B, Zimecki M, Wlaszczyk A, Kubler A (1997) Immunological status of septic and trauma patients. II. Proliferative response and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells from septic survivor, nonsurvivor and trauma patients: a correlation with the survival rate. Arch Immunol Ther Exp (Warsz) 45:277–284

CAS  PubMed  Google Scholar 

Antonakos N, Tsaganos T, Oberle V, Tsangaris I, Lada M, Pistiki A, Machairas N, Souli M, Bauer M, Giamarellos-Bourboulis EJ (2017) Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome. Crit Care 21:48

Article  PubMed  PubMed Central  Google Scholar 

Appoloni O, Vincent JL, Duchateau J (2002) Response of tumour necrosis factor-alpha to delayed in vitro monocyte stimulation in patients with septic shock is related to outcome. Clin Sci (Lond) 102:315–320

Article  CAS  PubMed  Google Scholar 

Ploder M, Pelinka L, Schmuckenschlager C, Wessner B, Ankersmit HJ, Fuerst W, Redl H, Roth E, Spittler A (2006) Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 25:129–134

CAS  PubMed  Google Scholar 

Hall MW, Geyer SM, Guo CY, Panoskaltsis-Mortari A, Jouvet P, Ferdinands J, Shay DK, Nateri J, Greathouse K, Sullivan R, Tran T, Keisling S, Randolph AG, Pediatric Acute Lung I, Sepsis Investigators Network PSI (2013) Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med 41:224–236

Article  PubMed  PubMed Central  Google Scholar 

Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, Carcillo JA (2011) Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 37:525–532

Article  CAS  PubMed  Google Scholar 

Levin G, Boyd JG, Day A, Hunt M, Maslove DM, Norman P, O'Callaghan N, Sibley S, Muscedere J. The relationship between immune status as measured by stimulated ex-vivo tumour necrosis factor alpha levels and the acquisition of nosocomial infections in critically ill mechanically ventilated patients. Intens Care Med Exp. 2020; 8.

Bline KE, Moore-Clingenpeel M, Hensley J, Steele L, Greathouse K, Anglim L, Hanson-Huber L, Nateri J, Muszynski JA, Ramilo O, Hall MW. Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis. Crit Care. 2020;24.

Muszynski JA, Nofziger R, Greathouse K, Nateri J, Hanson-Huber L, Steele L, Nicol K, Groner JI, Besner GE, Raffel C, Geyer S, El-Assal O, Hall MW (2014) Innate immune function predicts the development of nosocomial infection in critically injured children. Shock 42:313–321

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bline KE, Muszynski JA, Guess AJ, Menocha S, Moore-Clingenpeel MD, Popelka JK, Hensley JM, Steele LM, Goldthwaite IC, Jedreski KJ, Hall MW (2022) novel identification of myeloid-derived suppressor cells in children with septic shock. Pediatr Crit Care Med 23:e555–e563

Article  PubMed  Google Scholar 

Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260–268

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019-results from a systematic review and meta-analysis. Crit Care. 2020; 24.